1) head and neck squamous cell carcinoma
头颈部鳞癌
1.
Cetuximab plus other methods in the treatment of patients with head and neck squamous cell carcinomas(HNSCC);
西妥昔单抗联合其他治疗方法治疗头颈部鳞癌
2.
Study on the gene abnormalities of p53-mdm2 in head and neck squamous cell carcinoma;
头颈部鳞癌中p53-mdm2基因异常的研究
3.
The recent situation of study on the tumor suppressor gene FHIT in head and neck squamous cell carcinoma (A review);
FHIT抑癌基因在头颈部鳞癌中的研究进展(综述)
3) Head and neck squamous cell carcinoma
头颈部鳞状细胞癌
1.
Expression of fragile histidine traid in head and neck squamous cell carcinoma and relation with metastasis;
头颈部鳞状细胞癌组织中脆性组氨酸三联体基因的表达
2.
Background: Head and neck squamous cell carcinoma(HNSCC)is the sixth most common cancer worldwide.
研究背景: 头颈部鳞状细胞癌(Head and Neck Squamous Cell Carcinoma,HNSCC)是全球人类第六高发癌,目前主要治疗手段是手术,结合辅助性放疗和化疗。
4) Head and neck cancer
头颈部癌
1.
Reduction of postradiation xerostomia in patients with head and neck cancer by superior technology using 3D-RTPS;
三维放疗计划优化技术减少头颈部癌放射性口干症
2.
The rate of xerostomia is high in patients with head and neck cancer after conventional radiation therapy.
我们在2001年对20例头颈部癌放疗患者分成常规放疗组和3DCRT组行放射治疗,常规放疗组肿瘤剂量55。
3.
Objective:to evaluate the feasibility and the short-and medium-term clinical effects of ~(125)I implantation in recurrent or metastatic Head and Neck cancer.
方法:2003年1月～2008年5月对35例(男23例,女12例,年龄39～71岁,中位年龄为56岁)头颈部癌术后或放化疗后复发或转移,在局部浸润麻醉下,CT、B超或腔内镜引导125I粒子植入术,可评价病灶42个,病灶最大径2。
5) cervical carcinoma
宫颈鳞癌
1.
The expressions of Bag-1 and HSP70 protein in cervical intraepithelial neoplasia and cervical carcinoma
Bag-1、HSP70蛋白在宫颈上皮内瘤变及宫颈鳞癌中的表达和意义
2.
Objective:To research P120-catenin(P120ctn)and E-cadherin(E-cad)abnormal expression,distribution and biologic significance in samples of squamous cervical carcinoma(SCC)and SCC cell lines(Caski、Siha).
目的:探讨P120连环蛋白(P120catenin,P120ctn)及E-钙粘蛋白(E-cad-herin,E-cad)在宫颈鳞癌组织和宫颈鳞癌细胞系(Caski、Siha)中的表达、分布及其生物学意义。
3.
Objective To search a new method for screening high-risk group of cervical carcinoma.
方法免疫组织化学技术检测13例慢性宫颈炎、46例不同程度宫颈不典型增生、15例原位癌和20例宫颈鳞癌组织中瘦素的表达情况,同时免疫细胞化学技术检测以上各病例宫颈脱落细胞中瘦素的表达。
6) squamous cervical carcinoma
宫颈鳞癌
1.
Relationship between apoptosis and clinical biological behavior of squamous cervical carcinoma;
宫颈鳞癌组织中细胞凋亡的表达与临床生物学行为的关系
2.
Objective:To research the relationship between abnormal expression of P120-catenin and clinic pathologic significance in squamous cervical carcinoma(SCC),β-catenin,E-cadherin and Ki67 protein.
目的:研究P120连环蛋白(P120ctn)、β连环蛋白(β-cat)、E钙粘蛋白(E-cad)及Ki67蛋白在宫颈鳞癌中的表达及临床意义,分析P120ctn异常表达与β-cat、E-cad及Ki67蛋白异常表达的相互联系。
3.
Objective: To study the expressions of gene and protein levels of metastasis-enhancing gene S100A4 and adhesion molecule CD44v6,E-cad,integrinα_vβ_3 in early stage squamous cervical carcinoma (SCC), explore their roles in lymphatic metastasis of SCC.
目的:分别在基因水平和蛋白水平检测转移促进基因 S100A4 与黏附分子 CD44v6、E-cad、整合素 αvβ3在早期宫颈鳞癌(squamous cervical carcinoma ,SCC)中的表达,探讨其在淋巴结转移中的作用。
补充资料：外阴浅表浸润性鳞癌
外阴浅表浸润性鳞癌
该病是指癌的最大水平径线≤2cm，浸润深度≤1mm，外阴浅表浸润性鳞癌多见于大阴唇，其次为小阴唇、阴蒂和会阴部。这种癌可发生淋巴结转移、复发和死亡，与外阴Ⅰ期癌无差别。故有人建议可暂称Ⅰa期外阴鳞癌或外阴浅表浸润性鳞癌。因极少局部淋巴结转移，故预后佳，治疗原则与外阴鳞癌相同，以手术为主。但手术范围可适当缩小。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条